# Oral Dosage Form New Animal Drugs; Orbifloxacin Suspension
> **Food and Drug Administration** · Final rule. · Published 2010-05-12 · Effective 2010-05-12 · 75 FR 26646
## Document
- **Document number:** 2010-11245
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 75 FR 26646
- **CFR reference:** 21 CFR 520
- **Publication date:** 2010-05-12
- **Effective date:** 2010-05-12
- **HHS docket:** Docket No. FDA-2010-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Intervet, Inc. The NADA provides for the veterinary prescription use of an oral suspension containing orbifloxacin for the treatment of various bacterial infections in dogs and cats.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2010/05/12/2010-11245/oral-dosage-form-new-animal-drugs-orbifloxacin-suspension)
---
*AI Analytics · CC0 1.0*